TECH
NASDAQ
$71.64
Bio-Techne Corp (TECH)
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $70 (-2.29%)
Market Cap
$11B
PEG Ratio
0.96
Forward P/E
34.48
P/E Ratio
101.96
Price Chart
Valuation
Market Cap$11B
P/E101.96
Forward P/E34.48
PEG0.96
P/S9.17
P/B5.33
Profitability
Total Revenue (TTM)$1.21B
Gross Profit (TTM)$804M
EBITDA$257M
Profit Margin16.4%
Operating Margin24.2%
EPS$0.70
Financial Health
Free Cash Flow Yield2.41%
Dividend Yield0.45%
Growth & Risk
EPS 5Y CAGR-10.07%
Revenue 5Y CAGR+7.39%
FCF 5Y CAGR+3.72%
Dividends 5Y CAGR+4.56%
Beta (5Y)1.13
Sharpe Ratio0.78